Abstract
Delivery of peptides and proteins is critical for their clinical applications. Oral administration of these molecules is not feasible due to degradation in the gastrointestinal tract. Peptides and proteins are, hence, conventionally administered by the parenteral route. Transdermal route offers a good alternative for parenteral delivery of proteins resulting in improved patient compliance. However, due to their size and hydrophilicity, peptides and proteins are unable to permeate through the skin. To overcome the skin barrier, various physical enhancement techniques such as microporation, iontophoresis, sonophoresis, electroporation, and jet injectors have been investigated. These techniques enabling transdermal delivery of peptides and proteins will be discussed in this book chapter.
References
Abla N, Naik A, Guy RH, Kalia YN (2005) Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin. J Control Release Off J Control Release Soc 108(2–3):319–330
Arora A, Hakim I, Baxter J, Rathnasingham R, Srinivasan R, Fletcher DA et al (2007) Needle-free delivery of macromolecules across the skin by nanoliter-volume pulsed microjets. Proc Natl Acad Sci U S A 104(11):4255–4260
Bachhav YG, Kalia YN (2009) Stability of triptorelin in the presence of dermis and epidermis. Int J Pharm 378(1–2):149–151
Bachhav YG, Heinrich A, Kalia YN (2011) Using laser microporation to improve transdermal delivery of diclofenac: increasing bioavailability and the range of therapeutic applications. Eur J Pharm Biopharm 78(3):408–414
Badkar AV, Smith AM, Eppstein JA, Banga AK (2007) Transdermal delivery of interferon alpha-2B using microporation and iontophoresis in hairless rats. Pharm Res 24(7):1389–1395
Bal SM, Caussin J, Pavel S, Bouwstra JA (2008) In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci 35(3):193–202
Banga AK (2006), Therapeutic peptides and proteins formulation, processing, and delivery systems, 2nd ed, CRC Press/Taylor and Francis, Boca Raton FL, USA
Banga AK (2009) Microporation applications for enhancing drug delivery. Expert Opin Drug Deliv 6(4):343–354
Banga AK (2011) Transdermal and intradermal delivery of therapeutic agents: application of physical technologies, p 309 CRC Press. Taylor & Francis Group, Boca Raton, FL-33487, USA
Banga AK, Katakam M, Mitra R (1995) Transdermal iontophoretic delivery and degradation of vasopressin across human cadaver skin. Int J Pharm 116(2):211–216
Bos JD, Meinardi MMHM (2000) The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 9(3):165–169
Boucaud A, Montharu J, Machet L, Arbeille B, Machet MC, Patat F et al (2001) Clinical, histologic, and electron microscopy study of skin exposed to low-frequency ultrasound. Anat Rec 264(1):114–119
Boucaud A, Garrigue MA, Machet L, Vaillant L, Patat F (2002) Effect of sonication parameters on transdermal delivery of insulin to hairless rats. J Control Release Off J Control Release Soc 81(1–2):113–119
Bruce K. Redding J, Inventor, Dermisonics, Inc., Assignee. Substance delivery device patent US 6908448. 2005
Cazares-Delgadillo J, Naik A, Ganem-Rondero A, Quintanar-Guerrero D, Kalia YN (2007) Transdermal delivery of cytochrome C-A 12.4 kDa protein-across intact skin by constant-current iontophoresis. Pharm Res 24(7):1360–1368
Cevc G (2003) Transdermal drug delivery of insulin with ultradeformable carriers. Clin Pharmacokinet 42(5):461–474
Chang SL, Hofmann GA, Zhang L, Deftos LJ, Banga AK (2000) The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones. J Control Release 66(2–3):127–133
Chaturvedula A, Joshi DP, Anderson C, Morris RL, Sembrowich WL, Banga AK (2005) In vivo iontophoretic delivery and pharmacokinetics of salmon calcitonin. Int J Pharm 297(1–2):190–196
Chen Y, Shen Y, Guo X, Zhang C, Yang W, Ma M et al (2006) Transdermal protein delivery by a coadministered peptide identified via phage display. Nat Biotechnol 24(4):455–460
Choi HK, Flynn GL, Amidon GL (1990) Transdermal delivery of bioactive peptides: the effect of n-decylmethyl sulfoxide, pH, and inhibitors on enkephalin metabolism and transport. Pharm Res 7(11):1099–1106
Chu LY, Choi SO, Prausnitz MR (2010) Fabrication of dissolving polymer microneedles for controlled drug encapsulation and delivery: bubble and pedestal microneedle designs. J Pharm Sci 99(10):4228–4238
Cormier M, Johnson B, Ameri M, Nyam K, Libiran L, Zhang DD et al (2004) Transdermal delivery of desmopressin using a coated microneedle array patch system. J Control Release 97(3):503–511
Daddona PE, Matriano JA, Mandema J, Maa YF (2011) Parathyroid hormone (1–34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis. Pharm Res 28(1):159–165
Davis SP, Martanto W, Allen MG, Prausnitz MR (2005) Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans Biomed Eng 52(5):909–915
Duan D, Moeckly C, Gysbers J, Novak C, Prochnow G, Siebenaler K et al (2011) Enhanced delivery of topically-applied formulations following skin pre-treatment with a hand-applied, plastic microneedle array. Curr Drug Deliv 8(5):557–565
Dubey S, Kalia YN (2010) Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins. J Control Release 145(3):203–209
Dubey S, Kalia YN (2011) Electrically-assisted delivery of an anionic protein across intact skin: cathodal iontophoresis of biologically active ribonuclease T1. J Control Release Off J Control Release Soc 152(3):356–362
Dubey S, Perozzo R, Scapozza L, Kalia YN (2011) Noninvasive transdermal iontophoretic delivery of biologically active human basic fibroblast growth factor. Mol Pharm 8(4):1322–1331
Escobar-Chavez JJ, Bonilla-Martinez D, Villegas-Gonzalez MA, Revilla-Vazquez AL (2009) Electroporation as an efficient physical enhancer for skin drug delivery. J Clin Pharmacol 49(11):1262–1283
Foldvari M, Badea I, Kumar P, Wettig S, Batta R, King MJ et al (2011) Biphasic vesicles for topical delivery of interferon alpha in human volunteers and treatment of patients with human papillomavirus infections. Curr Drug Deliv 8(3):307–319
Fomsgaard A, Bragstad K, Inventors, Inventor Statens Serum Institute, Assignee. Optimized influenza vaccines patent US 2011/0229518 A1. 2011
Getie M, Wohlrab J, Neubert RHH (2005) Dermal delivery of desmopressin acetate using colloidal carrier systems. J Pharm Pharmacol 57(4):423–427
Gill HS, Prausnitz MR (2007) Coated microneedles for transdermal delivery. J Control Release 117(2):227–237
Gomez C, Benito M, Teijon JM, Blanco MD (2012) Novel methods and devices to enhance transdermal drug delivery: the importance of laser radiation in transdermal drug delivery. Ther Deliv 3(3):373–388
Gupta J, Felner EI, Prausnitz MR (2011) Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjects. Diabetes Technol Ther 13(4):451–456
Haq MI, Smith E, John DN, Kalavala M, Edwards C, Anstey A et al (2009) Clinical administration of microneedles: skin puncture, pain and sensation. Biomed Microdevices 11(1):35–47
Healey TT, Dupuy DE (2011) Radiofrequency ablation: a safe and effective treatment in nonoperative patients with early-stage lung cancer. Cancer J 17(1):33–37
Henry S, McAllister DV, Allen MG, Prausnitz MR (1998) Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci 87(8):922–925
Huang YY, Wu SM (1996) Stability of peptides during iontophoretic transdermal delivery. Int J Pharm 131(1):19–23
Ito Y, Nakahigashi T, Yoshimoto N, Ueda Y, Hamasaki N, Takada K (2012) Transdermal insulin application system with dissolving microneedles. Diabetes Technol Ther 14(10):891–899
Kalluri H, Banga AK (2011a) Formation and closure of microchannels in skin following microporation. Pharm Res 28(1):82–94
Kalluri H, Banga AK (2011b) Transdermal delivery of proteins. AAPS PharmSciTech 12(1):431–441
Katikaneni S, Badkar A, Nema S, Banga AK (2009) Molecular charge mediated transport of a 13 kD protein across microporated skin. Int J Pharm 378(1–2):93–100
Kaushik S, Hord AH, Denson DD, McAllister DV, Smitra S, Allen MG et al (2001) Lack of pain associated with microfabricated microneedles. Anesth Analg 92(2):502–504
Kim HS, Cho EJ, Park YM, Kim HO, Lee JY (2011) Punch excision combined with erbium:YAG fractional laser: its application on different types of scars in Asian patients (a pilot study). J Cosmet Laser Ther 13(4):196–199
Kim YC, Jarrahian C, Zehrung D, Mitragotri S, Prausnitz MR (2012) Delivery systems for intradermal vaccination. Curr Top Microbiol Immunol 351:77–112
Knorr F, Lademann J, Patzelt A, Sterry W, Blume-Peytavi U, Vogt A (2009) Follicular transport route–research progress and future perspectives. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV 71(2):173–180
Kochhar C, Imanidis G (2004) In vitro transdermal iontophoretic delivery of leuprolide under constant current application. J Control Release Off J Control Release Soc 98(1):25–35
Kost J, Pliquett U, Mitragotri S, Yamamoto A, Langer R, Weaver J (1996) Synergistic effect of electric field and ultrasound on transdermal transport. Pharm Res 13(4):633–638
Kumar V, Banga AK (2012) Modulated iontophoretic delivery of small and large molecules through microchannels. Int J Pharm 434(1–2):106–114
Kushner J, Blankschtein D, Langer R (2008) Heterogeneity in skin treated with low-frequency ultrasound. J Pharm Sci 97(10):4119–4128
Le L, Kost J, Mitragotri S (2000) Combined effect of low-frequency ultrasound and iontophoresis: applications for transdermal heparin delivery. Pharm Res 17(9):1151–1154
Lee K, Jung H (2012) Drawing lithography for microneedles: a review of fundamentals and biomedical applications. Biomaterials 33(30):7309–7326
Lee V, Hashida M, Mizushima Y (eds) (1995) Trends and future perspectives in peptide and protein drug delivery. Harwood academic publishers, Chur
Levin G, Gershonowitz A, Sacks H, Stern M, Sherman A, Rudaev S et al (2005) Transdermal delivery of human growth hormone through RF-microchannels. Pharm Res 22(4):550–555
Li G, Badkar A, Nema S, Kolli CS, Banga AK (2009) In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. Int J Pharm 368(1–2):109–115
Lopes LB, Furnish E, Komalavilas P, Seal BL, Panitch A, Bentley MVLB et al (2008) Enhanced skin penetration of P20 phosphopeptide using protein transduction domains. Eur J Pharm Biopharm 68(2):441–445
Luis J, Park EJ, Meyer RJ, Smith NB (2007) Rectangular cymbal arrays for improved ultrasonic transdermal insulin delivery. J Acoust Soc Am 122(4):2022–2030
Lvovich VF, Matthews E, Riga AT, Kaza L (2010) AC electrokinetic platform for iontophoretic transdermal drug delivery. J Control Release Off J Control Release Soc 145(2):134–140
Manosroi A, Lohcharoenkal W, Gotz F, Werner RG, Manosroi W, Manosroi J (2011) Cellular uptake enhancement of Tat-GFP fusion protein loaded in elastic niosomes. J Biomed Nanotechnol 7(3):366–376
Martanto W, Davis SP, Holiday NR, Wang J, Gill HS, Prausnitz MR (2004) Transdermal delivery of insulin using microneedles in vivo. Pharm Res 21(6):947–952
Medi BM, Singh J (2003) Electronically facilitated transdermal delivery of human parathyroid hormone (1–34). Int J Pharm 263(1–2):25–33
Mitragotri S (2006) Current status and future prospects of needle-free liquid jet injectors. Nat Rev Drug Discov 5(7):543–548
Mitragotri S, Blankschtein D, Langer R (1995) Ultrasound-mediated transdermal protein delivery. Science 269(5225):850–853
Mitragotri S, Farrell J, Tang H, Terahara T, Kost J, Langer R (2000) Determination of threshold energy dose for ultrasound-induced transdermal drug transport. J Control Release Off J Control Release Soc 63(1–2):41–52
Mudry B, Guy RH, Begona D-CM (2006) Prediction of iontophoretic transport across the skin. J Control Release Off J Control Release Soc 111(3):362–367
Mutalik S, Parekh HS, Davies NM, Udupa N (2009) A combined approach of chemical enhancers and sonophoresis for the transdermal delivery of tizanidine hydrochloride. Drug Deliv 16(2):82–91
Nair V, Panchagnula R (2003) Physicochemical considerations in the iontophoretic delivery of a small peptide: in vitro studies using arginine vasopressin as a model peptide. Pharmacol Res 48(2):175–182
Ogura M, Paliwal S, Mitragotri S (2008) Low-frequency sonophoresis: current status and future prospects. Adv Drug Deliv Rev 60(10):1218–1223
Park EJ, Dodds J, Smith NB (2008) Dose comparison of ultrasonic transdermal insulin delivery to subcutaneous insulin injection. Int J Nanomedicine 3(3):335–341
Peters EE, Ameri M, Wang X, Maa YF, Daddona PE (2012) Erythropoietin-coated ZP-microneedle transdermal system: preclinical formulation, stability, and delivery. Pharm Res 29(6):1618–1626
Phipps JB, Padmanabhan RV, Lattin GA (1989) Iontophoretic delivery of model inorganic and drug ions. J Pharm Sci 78(5):365–369
Pikal MJ, Shah S (1990) Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes. Pharm Res 7(3):222–229
Pillai O, Panchagnula R (2003) Transdermal delivery of insulin from poloxamer gel: ex vivo and in vivo skin permeation studies in rat using iontophoresis and chemical enhancers. J Control Release 89(1):127–140
Pillai O, Borkute SD, Sivaprasad N, Panchagnula R (2003) Transdermal iontophoresis of insulin. II. Physicochemical considerations. Int J Pharm 254(2):271–280
Prausnitz MR, Langer R (2008) Transdermal drug delivery. Nat Biotechnol 26(11):1261–1268
Prausnitz MR, Bose VG, Langer R, Weaver JC (1993) Electroporation of mammalian skin - a mechanism to enhance transdermal drug-delivery. Proc Natl Acad Sci U S A 90(22):10504–10508
Rader RA (2011) FDA biopharmaceutical product approvals and trends: 2011 Biotechnology Information Institute. http://www.biopharma.com/approvals_2011.html. Accessed 12 Oct 2012
Raiman J, Koljonen M, Huikko K, Kostiainen R, Hirvonen J (2004) Delivery and stability of LHRH and Nafarelin in human skin: the effect of constant/pulsed iontophoresis. Eur J Pharm Sci Off J Eur Fed Pharm Sci 21(2–3):371–377
Rao R, Nanda S (2009) Sonophoresis: recent advancements and future trends. J Pharm Pharmacol 61(6):689–705
Salas N, Castle SM, Leveillee RJ (2011) Radiofrequency ablation for treatment of renal tumors: technological principles and outcomes. Expert Rev Med Devices 8(6):695–707
Saurer EM, Flessner RM, Sullivan SP, Prausnitz MR, Lynn DM (2010) Layer-by-layer assembly of DNA- and protein-containing films on microneedles for drug delivery to the skin. Biomacromolecules 11(11):3136–3143
Schuetz YB, Naik A, Guy RH, Vuaridel E, Kalia YN (2005) Transdermal iontophoretic delivery of vapreotide acetate across porcine skin in vitro. Pharm Res 22(8):1305–1312
Singh N, Kalluri H, Herwadkar A, Badkar A, Banga AK (2012) Transcending the skin barrier to deliver peptides and proteins using active technologies. Crit Rev Ther Drug Carrier Syst 29(4):265–298
Smith NB, Lee S, Maione E, Roy RB, McElligott S, Shung KK (2003) Ultrasound-mediated transdermal transport of insulin in vitro through human skin using novel transducer designs. Ultrasound Med Biol 29(2):311–317
Song YK, Hyun SY, Kim HT, Kim CK, Oh JM (2011) Transdermal delivery of low molecular weight heparin loaded in flexible liposomes with bioavailability enhancement: comparison with ethosomes. J Microencapsul 28(3):151–158
Tas C, Mansoor S, Kalluri H, Zarnitsyn VG, Choi SO, Banga AK et al (2012) Delivery of salmon calcitonin using a microneedle patch. Int J Pharm 423(2):257–263
Tezel A, Sens A, Tuchscherer J, Mitragotri S (2001) Frequency dependence of sonophoresis. Pharm Res 18(12):1694–1700
Tezel A, Sens A, Mitragotri S (2003) Description of transdermal transport of hydrophilic solutes during low-frequency sonophoresis based on a modified porous pathway model. J Pharm Sci 92(2):381–393
Tezel A, Dokka S, Kelly S, Hardee GE, Mitragotri S (2004) Topical delivery of anti-sense oligonucleotides using low-frequency sonophoresis. Pharm Res 21(12):2219–2225
Clinical Trials – U-Strip/Insulin Patch: Transdermal Specialties, Inc (2012) http://www.transdermalspecialties.com/clinicaltrials.html. Accessed 12 Oct 2012
van der Maaden K, Jiskoot W, Bouwstra J (2012) Microneedle technologies for (trans)dermal drug and vaccine delivery. J Control Release 161(2):645–655
Vyteris announces positive results from phase II clinical trial of transdermal patch for female infertility. COMTEX News Network; 2010
Weimann LJ, Wu J (2002) Transdermal delivery of poly-l-lysine by sonomacroporation. Ultrasound Med Biol 28(9):1173–1180
Yu J, Bachhav YG, Summer S, Heinrich A, Bragagna T, Bohler C et al (2010) Using controlled laser-microporation to increase transdermal delivery of prednisone. J Control Release 148(1):e71–e73
Yu J, Kalaria DR, Kalia YN (2011) Erbium:YAG fractional laser ablation for the percutaneous delivery of intact functional therapeutic antibodies. J Control Release 156(1):53–59
Zhang I, Shung KK, Edwards DA (1996) Hydrogels with enhanced mass transfer for transdermal drug delivery. J Pharm Sci 85(12):1312–1316
Zhang W, Gao J, Zhu Q, Zhang M, Ding X, Wang X et al (2010) Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles. Int J Pharm 402(1–2):205–212
Zhao YL, Murthy SN, Manjili MH, Guan LJ, Sen A, Hui SW (2006) Induction of cytotoxic T-lymphocytes by electroporation-enhanced needle-free skin immunization. Vaccine 24(9):1282–1290
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zhou, Y., Kumar, V., Herwadkar, A., Banga, A.K. (2017). Transdermal Delivery of Peptides and Proteins by Physical Methods. In: Dragicevic, N., I. Maibach, H. (eds) Percutaneous Penetration Enhancers Physical Methods in Penetration Enhancement. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53273-7_27
Download citation
DOI: https://doi.org/10.1007/978-3-662-53273-7_27
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-53271-3
Online ISBN: 978-3-662-53273-7
eBook Packages: MedicineMedicine (R0)